Deregulation of E-cadherin by human papillomavirus is not confined to high-risk, cancer-causing types

British Journal of Dermatology

Volumn 163, Issue 6, 2010, Pages 1253-1263

  Leong, C M ^a   Doorbar, J ^b   Nindl, I ^c   Yoon, H S ^a   Hibma, M H ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

antigen presenting cells; E cadherin; human papillomavirus; oncogenic viruses

Indexed keywords

P CADHERIN; T6 ANTIGEN; UVOMORULIN;

ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONDYLOMA ACUMINATUM; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LANGERHANS CELL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION; WART VIRUS;

CADHERINS; CONDYLOMATA ACUMINATA; EPIDERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LANGERHANS CELLS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SKIN NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

EID: 78649670339     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09968.x     Document Type: Article

References (30)

1. Halbleib JM, Nelson WJ,. Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev 2006; 20: 3199-214.
2. Wakita H, Yamamoto Y, Furukawa F,. Aberrant suprabasal P-cadherin expression in acanthotic but not psoriatic thickened epidermis. Arch Dermatol Res 2003; 295 (Suppl. 1): S71-4.
3. Vasioukhin V, Bowers E, Bauer C, et al. Desmoplakin is essential in epidermal sheet formation. Nat Cell Biol 2001; 3: 1076-85.
4. Tinkle CL, Lechler T, Pasolli HA, et al. Conditional targeting of E-cadherin in skin: insights into hyperproliferative and degenerative responses. Proc Natl Acad Sci USA 2004; 101: 552-7.
5. Makrilia N, Kollias A, Manolopoulos L, et al. Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest 2009; 27: 1023-37.
6. Tang A, Amagai M, Granger LG, et al. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 1993; 361: 82-5.
7. Zhang B, Chen W, Roman A,. The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci USA 2006; 103: 437-42.
8. Scheffner M, Werness BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-36.
9. De Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology 2004; 324: 17-27.
10. Syrjanen S,. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005; 32 (Suppl. 1): S59-66.
11. Gewirtzman A, Bartlett B, Tyring S,. Epidermodysplasia verruciformis and human papilloma virus. Curr Opin Infect Dis 2008; 21: 141-6.
12. Forslund O, Ly H, Reid C, et al. A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol 2003; 149: 64-73.
13. Weissenborn SJ, Nindl I, Purdie K, et al. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 2005; 125: 93-7.
14. Michael KM, Waterboer T, Sehr P, et al. Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog 2008; 4: e1000091.
15. Matthews K, Leong CM, Baxter L, et al. Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin. J Virol 2003; 77: 8378-85.
16. Leong CM, Doorbar J, Nindl I, et al. Loss of epidermal Langerhans cells occurs in human papillomavirus alpha, gamma, and mu but not beta genus infections. J Invest Dermatol 2010; 130: 472-80.
17. Kleter B, Van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37: 2508-17.
18. Kleter B, Van Doorn LJ, Ter Schegget J, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998; 153: 1731-9.
19. Brink AA, Lloveras B, Nindl I, et al. Development of a general-primer-PCR-reverse-line-blotting system for detection of beta and gamma cutaneous human papillomaviruses. J Clin Microbiol 2005; 43: 5581-7.
20. Peh WL, Middleton K, Christensen N, et al. Life cycle heterogeneity in animal models of human papillomavirus-associated disease. J Virol 2002; 76: 10401-16.
21. Middleton K, Peh W, Southern S, et al. Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol 2003; 77: 10186-201.
22. Nakopoulou L, Gakiopoulou-Givalou H, Karayiannakis AJ, et al. Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival. Histopathology 2002; 40: 536-46.
23. Crish JF, Bone F, Balasubramanian S, et al. Suprabasal expression of the human papillomavirus type 16 oncoproteins in mouse epidermis alters expression of cell cycle regulatory proteins. Carcinogenesis 2000; 21: 1031-7.
24. Barcelos AC, Sotto MN,. Comparative analysis of the expression of cytokeratins (1, 10, 14, 16, 4), involucrin, filaggrin and E-cadherin in plane warts and epidermodysplasia verruciformis plane wart-type lesions. J Cutan Pathol 2009; 36: 647-54.
25. Caberg JH, Hubert P, Herman L, et al. Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20. Cancer Immunol Immunother 2009; 58: 39-47.
26. Laurson J, Khan S, Chung R, et al. Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein. Carcinogenesis 2010; 31: 918-26.
27. Caberg JH, Hubert PM, Begon DY, et al. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcinogenesis 2008; 29: 1441-7.
28. Tsai CN, Tsai CL, Tse KP, et al. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci USA 2002; 99: 10084-9.
29. Arora P, Kim EO, Jung JK, et al. Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b. Cancer Lett 2008; 261: 244-52.
30. Lee JO, Kwun HJ, Jung JK, et al. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 2005; 24: 6617-25.